COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 109

Article download: 50

Panacea Journal of Medical Sciences


Recent advancements in ropinirole hydrochloride embedded nano-techniques in Parkinson’s treatment


Full Text PDF Share on Facebook Share on Twitter


Research Article

Author Details : Manoj Kumar Katual*, Gurfateh Singh, S L. Harikumar

Volume : 9, Issue : 3, Year : 2019

Article Page : 92-103


Suggest article by email

Abstract

Parkinson's Disease (PD) is effecting 7-10 million people of worldwide as the report of WHO 2014. It has proved to be 2nd most a neuro-degenerative disorder of the central nervous system (CNS). It occurs due to the death of dopamine-generating cells in the substantia-nigra, a region of the midbrain. It is characterized by tremor, rigidity, bradykinesia, dementia, depression and falls or emerges with the progression of the disease. Ropinirole HCl is a low molecular weight, highly water soluble drug. It is rapidly absorbed from the G.I.T and mean peak plasma concentrations have been achieved within 1.5 h after oral doses. The oral bioavailability of Ropinirole HCl is 50% due to extensive first pass metabolism by the liver. Its mean plasma half-life is 5–6 h. The present study tries to enlighten the prior art related to Parkinson's treatment and to prepare Ropinirole HCl loaded Nano-structured lipid carriers (NLC) that may overcome the problem of bioavailability and bypass the blood brain barrier by preparing the intra-nasal drug delivery targeted to the brain thereby decreasing the dosing frequency and increasing patient compliance.

Keywords: Parkinson's Disease, Bioavailability, NLC, Nano-technology.

Doi : 10.18231/j.pjms.2019.023

How to cite : Katual M K, Singh G, Harikumar S L, Recent advancements in ropinirole hydrochloride embedded nano-techniques in Parkinson’s treatment. Panacea J Med Sci 2019;9(3):92-103

Copyright © 2019 by author(s) and Panacea J Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)